Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, announced it has appointed Anne McGeorge, M.S., CPA, to its Board of Directors, and as Audit Committee Chair. Ms. McGeorge is a seasoned finance executive with decades of experience advising healthcare and life sciences organizations. “On behalf of Nimbus’ leadership team and Board, I am delighted to welcome Anne McGeorge to our Board of Directors. Anne’s technical acumen across all areas of finance for both private and public companies will be an asset to our business,” said Bruce Booth, Chairman of Nimbus. Jeb Keiper, Chief Executive Officer of Nimbus added, “As we expand our team and prepare to initiate clinical development of a second program, I am looking forward to partnering with Anne and the rest of the Board to continue to chart the future of Nimbus.”